Page last updated: 2024-10-15

buciclovir

Description

buciclovir: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135410214
CHEMBL ID1744042
SCHEMBL ID349779
MeSH IDM0113632

Synonyms (20)

Synonym
r-9-(3,4-dihydroxybutyl)guanine
2-amino-9-[(3r)-3,4-dihydroxybutyl]-1h-purin-6-one
86304-28-1
(r)-9-(3,4-dihydroxybutyl)guanine
buciclovir
2-amino-9-[(3r)-3,4-dihydroxybutyl]-3h-purin-6-one
dhbg-(r)
6h-purin-6-one, 2-amino-9-(3,4-dihydroxybutyl)-1,9-dihydro-, (r)-
2-amino-9-((r)-3,4-dihydroxybutyl-9h-purin-6(1h)-on
buciclovir [inn]
brn 5073058
bucyclovir
buciclovirum [latin]
CHEMBL1744042
buciclovirum
unii-4g4z4676is
4g4z4676is ,
SCHEMBL349779
DTXSID30235484
Q27259556

Research Excerpts

Overview

Buciclovir is an antiherpes, acyclic guanosine analog activated by the viral thymidine kinase and inhibiting viral DNA synthesis in infected cells.

ExcerptReference
"Buciclovir is an example of an antiherpes, acyclic guanosine analog activated by the viral thymidine kinase and inhibiting viral DNA synthesis in infected cells. "( Critical determinants of antiherpes efficacy of buciclovir and related acyclic guanosine analogs.
Datema, R; Ericson, AC; Field, HJ; Larsson, A; Stenberg, K, 1987
)

Pharmacokinetics

ExcerptReference
" The extremely short half-life in plasma and the high clearance of 9-(4-hydroxybutyl)guanine as compared with those of (R)-9-(3,4-dihydroxybutyl)guanine probably made 9-(4-hydroxybutyl)guanine inefficacious when given intraperitoneally or orally to mice infected with herpesvirus."( Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine.
Aoki, FY; Datema, R; Ericson, AC; Johansson, NG; Larsson, A; Oberg, B; Yisak, WA, 1985
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID82116Antiviral activity against HIV-1 was determined; No inhibition1990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Synthesis of new (+-)-3,5-dihydroxypentyl nucleoside analogues from 1-amino-5-(benzyloxy)pentan-3-ol and their antiviral evaluation.
AID90940Antiviral activity against HCMV was determined; No inhibition1990Journal of medicinal chemistry, Sep, Volume: 33, Issue:9
Synthesis of new (+-)-3,5-dihydroxypentyl nucleoside analogues from 1-amino-5-(benzyloxy)pentan-3-ol and their antiviral evaluation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (81.25)18.7374
1990's1 (6.25)18.2507
2000's1 (6.25)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]